Venrock Partners Management, Llc - Net Worth and Insider Trading

Venrock Partners Management, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Venrock Partners Management, Llc owns 6 companies in total, including Bellerophon Therapeutics Inc (BLPH) , Quantenna Communications Inc (QTNA) , and Achaogen Inc (AKAOQ) among others .

Click here to see the complete history of Venrock Partners Management, Llc’s form 4 insider trades.

Insider Ownership Summary of Venrock Partners Management, Llc

Ticker	Comapny	Transaction Date	Type of Owner
BLPH	Bellerophon Therapeutics Inc	2018-08-13	10 percent owner
QTNA	Quantenna Communications Inc	2016-11-02	10 percent owner
AKAOQ	Achaogen Inc	2014-03-17	10 percent owner
		2013-11-15	10 percent owner
		2013-09-18	10 percent owner
		2010-04-21	10 percent owner

Venrock Partners Management, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Venrock Partners Management, Llc Ownership Network

Ownership Network List of Venrock Partners Management, Llc

No Data

Ownership Network Relation of Venrock Partners Management, Llc

Venrock Partners Management, Llc Owned Company Details

What does Bellerophon Therapeutics Inc do?

Who are the key executives at Bellerophon Therapeutics Inc?

Venrock Partners Management, Llc is the 10 percent owner of Bellerophon Therapeutics Inc. Other key executives at Bellerophon Therapeutics Inc include 10 percent owner Puissance Life Science Opportunities Fund Vi , VP of Business Operations Parag Suresh Shah , and See Remarks Martin Dekker .

Bellerophon Therapeutics Inc (BLPH) Insider Trades Summary

Over the past 18 months, Venrock Partners Management, Llc made no insider transaction in Bellerophon Therapeutics Inc (BLPH). Other recent insider transactions involving Bellerophon Therapeutics Inc (BLPH) include a net sale of 1,076,841 shares made by Puissance Life Science Opportunities Fund Vi ,

In summary, during the past 3 months, insiders sold 0 shares of Bellerophon Therapeutics Inc (BLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,076,841 shares of Bellerophon Therapeutics Inc (BLPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,076,841 shares.

Bellerophon Therapeutics Inc (BLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bellerophon Therapeutics Inc Insider Transactions

No Available Data

What does Quantenna Communications Inc do?

Who are the key executives at Quantenna Communications Inc?

Venrock Partners Management, Llc is the 10 percent owner of Quantenna Communications Inc. Other key executives at Quantenna Communications Inc include SVP Mktg & Business Dev. Lionel Bonnot , 10 percent owner Sequoia Capital Usgf Principals Fund V, L.p. , and 10 percent owner Michael J Moritz .

Quantenna Communications Inc (QTNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Quantenna Communications Inc (QTNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Quantenna Communications Inc (QTNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Quantenna Communications Inc (QTNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Quantenna Communications Inc Insider Transactions

No Available Data

What does Achaogen Inc do?

Who are the key executives at Achaogen Inc?

Venrock Partners Management, Llc is the 10 percent owner of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .

Achaogen Inc (AKAOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achaogen Inc Insider Transactions

No Available Data

What does Anacor Pharmaceuticals Inc do?

Who are the key executives at Anacor Pharmaceuticals Inc?

Venrock Partners Management, Llc is the 10 percent owner of Anacor Pharmaceuticals Inc. Other key executives at Anacor Pharmaceuticals Inc include Executive VP and CFO Graeme Bell , EVP and General Counsel Ryan T Sullivan , and director & President and CEO Paul L Berns .

Anacor Pharmaceuticals Inc (ANAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Anacor Pharmaceuticals Inc (ANAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anacor Pharmaceuticals Inc (ANAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anacor Pharmaceuticals Inc (ANAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Anacor Pharmaceuticals Inc Insider Transactions

No Available Data

What does Acceleron Pharma Inc do?

Who are the key executives at Acceleron Pharma Inc?

Venrock Partners Management, Llc is the 10 percent owner of Acceleron Pharma Inc. Other key executives at Acceleron Pharma Inc include EVP & Chief Commercial Officer Sujay Kango , SVP & CFO and Treasurer Kevin F Mclaughlin , and SVP & General Counsel and Sec. Adam M Veness .

Acceleron Pharma Inc (XLRN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acceleron Pharma Inc (XLRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acceleron Pharma Inc (XLRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acceleron Pharma Inc (XLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Acceleron Pharma Inc Insider Transactions

No Available Data

What does Alimera Sciences Inc do?

Who are the key executives at Alimera Sciences Inc?

Venrock Partners Management, Llc is the 10 percent owner of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , other: Chairman Emeritus C. Daniel Myers , and 10 percent owner David Edward Johnson .

Alimera Sciences Inc (ALIM) Insider Trades Summary

Over the past 18 months, Venrock Partners Management, Llc made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 579,000 shares of Alimera Sciences Inc (ALIM) were sold and 579,000 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alimera Sciences Inc Insider Transactions

No Available Data

Venrock Partners Management, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Venrock Partners Management, Llc. You might contact Venrock Partners Management, Llc via mailing address: 3340 Hillview Avenue, Palo Alto Ca 94304.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.